Sitryx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Sitryx Therapeutics's estimated annual revenue is currently $9.5M per year.
- Sitryx Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Sitryx Therapeutics has 61 Employees.
- Sitryx Therapeutics grew their employee count by -2% last year.
Sitryx Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CSO | Reveal Email/Phone |
2 | Head People & Culture | Reveal Email/Phone |
3 | Head Early Clinical Development | Reveal Email/Phone |
4 | Chief Scientific Officer at Sitryx | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Associate Director Finance | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Chief Business Officer | Reveal Email/Phone |
9 | IT Project Manager / IT Support | Reveal Email/Phone |
10 | Portfolio Manager | Reveal Email/Phone |
Sitryx Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Sitryx Therapeutics?
Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
keywords:N/AN/A
Total Funding
61
Number of Employees
$9.5M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sitryx Therapeutics News
Eli Lilly immunometabolism partner Sitryx Therapeutics out of Oxford ... at Sobi before choosing a different path here at GSK-backed Sitryx.
Sitryx is a global biopharmaceutical company pioneering the field of immunometabolism. The company's proprietary platform and Product Engine are...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.5M | 61 | 13% | N/A |
#2 | $11.5M | 61 | -26% | N/A |
#3 | $5.8M | 63 | -3% | N/A |
#4 | $15.6M | 64 | 39% | N/A |
#5 | $9.8M | 64 | 33% | N/A |